Malgorzata Szolkowska, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Edith Marom, The Chaim Sheba Medical Center, Ramat Gan, Israel

Nicolas Girard, Institut Curie, Paris, France

Andreas Rimner, Memorial Sloan Kettering Cancer Center, New York, USA

Pam Bruce, Executive Director of ITMIG, New York, USA

In alphabetical order: 

Katarzyna Blasinska, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Frank Detterbeck, Yale University School of Medicine, New Haven, CT, USA

Conrad Falkson, Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada

Nicolas Girard, Institut Curie, Paris, France

Maria Leite, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK

Edith Marom, The Chaim Sheba Medical Center, Ramat Gan, Israel

Arun Rajan, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA

Andreas Rimner, Memorial Sloan Kettering Cancer Center, New York, USA

Anja Roden, Mayo Clinic Rochester, Rochester, MN, USA

Paul Van Schil, Antwerp University Hospital, Edegem (Antwerp), Belgium

Malgorzata Szolkowska, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Alper Toker, West Virginia University Heart and Vascular Institute, USA